Tekla Life Sciences Investors (HQL) — Cash Flow Reinvestment Rate
Tekla Life Sciences Investors (HQL) has a Cash Flow Reinvestment Rate of 0.00x as of March 2015, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $45.81K. See how much free cash does Tekla Life Sciences Investors generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tekla Life Sciences Investors Cash Flow Reinvestment Rate (2008–2013)
Historical reinvestment intensity for Tekla Life Sciences Investors across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Tekla Life Sciences Investors generate cash.
Annual Cash Flow Reinvestment Rate for Tekla Life Sciences Investors (2008–2013)
Year-by-year capital reinvestment analysis for Tekla Life Sciences Investors. See Tekla Life Sciences Investors leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $9.47K | $0.00 | — |
| 2012 | 0.00x | $0.00 | $21.11 Million | $0.00 | — |
| 2011 | 0.00x | $0.00 | $118.30 Million | $0.00 | — |
| 2010 | 0.00x | $0.00 | $1.90 Million | $0.00 | — |
| 2009 | 0.00x | $0.00 | $13.00 Million | $0.00 | — |
| 2008 | 0.00x | $0.00 | $11.80 Million | $0.00 | — |